State of the Science Summit - Breast Cancer: Chaired by Komal Jhaveri, MD, FACP

Commentary
Article

In Partnership With:

State of the Science Summit - Breast Cancer: Chaired by Komal Jhaveri, MD, FACP

State of the Science Summit - Breast Cancer: Chaired by Komal Jhaveri, MD, FACP

Speakers

  • Sherry Shen, MD | Memorial Sloan Kettering Cancer Center
  • Neil Iyengar, MD | Memorial Sloan Kettering Cancer Center
  • Joshua Drago, MD, MS | Memorial Sloan Kettering Cancer Center
  • Chau Dang, MD | Memorial Sloan Kettering Cancer Center
  • Pedram Razavi, MD, PhD | Memorial Sloan Kettering Cancer Center

Topics

  • Treatment Crossroads: Choice of Adjuvant CDK4/6 in Breast Cancer
  • CDK4/6 Inhibitors and Sequencing Beyond CDK4/6 Inhibitors in HR+/HER2– Metastatic Breast Cancer
  • Case Presentations: HER2+ and HER2-Low Breast Cancer
  • Year in Review: Top Abstracts of 2023
  • Biomarker Testing in Metastatic Breast Cancer: When? Who? Why?

Interested in virtually attending an IPC event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Clinicians referring a patient to MSK can do so by visiting msk.org/refer, emailing referapatient@mskcc.org, or by calling 833-315-2722.
Related Videos
Rita Nanda, MD
Video 5 - "AE Management with CDK4/6 Inhibitors: Strategies for Treatment Continuity and Optimal Patient Outcomes"
Saad Z. Usmani, MD, MBA, FACP, FASCO
Rita Nanda, MD
Siddartha Yadav, MD, FACP
Nan Chen, MD
Video 4 - "The Evolving Treatment Landscape with CDK4/6 Inhibitors in Early HR+/HER2- Breast Cancer"
Margaret E. Gatti-Mays, MD, MPH, FACP, of The Ohio State University Comprehensive Cancer Center
Saad Z. Usmani, MD, MBA, FACP, FASCO, chief, Myeloma Service, Memorial Sloan Kettering Cancer Center
A panel of 5 experts on renal cell carcinoma